[{"address1": "10285 Science Center Drive", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 900 2660", "website": "https://arcturusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.", "fullTimeEmployees": 174, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph E. Payne M.Sc.", "age": 53, "title": "Founder, President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1062000, "exercisedValue": 0, "unexercisedValue": 2086450}, {"maxAge": 1, "name": "Dr. Padmanabh  Chivukula Ph.D.", "age": 46, "title": "Founder, Chief Scientific Officer, COO & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 778000, "exercisedValue": 0, "unexercisedValue": 1370925}, {"maxAge": 1, "name": "Mr. Lance  Kurata", "title": "Chief Legal Officer", "fiscalYear": 2024, "totalPay": 680000, "exercisedValue": 0, "unexercisedValue": 3125}, {"maxAge": 1, "name": "Mr. Joseph  Roberts", "age": 43, "title": "Interim Principal Financial & Accounting Officer and Controller", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Neda  Safarzadeh", "title": "Vice President and Head of IR/PR & Marketing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Natasha O. Bowman", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin T. Skol", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.59, "open": 7.7, "dayLow": 7.41, "dayHigh": 7.76, "regularMarketPreviousClose": 7.59, "regularMarketOpen": 7.7, "regularMarketDayLow": 7.41, "regularMarketDayHigh": 7.76, "payoutRatio": 0.0, "beta": 2.24, "forwardPE": -2.8312955, "volume": 415288, "regularMarketVolume": 415288, "averageVolume": 837955, "averageVolume10days": 575350, "averageDailyVolume10Day": 575350, "bid": 7.46, "ask": 7.57, "bidSize": 1, "askSize": 1, "marketCap": 213959536, "fiftyTwoWeekLow": 5.85, "fiftyTwoWeekHigh": 24.17, "allTimeHigh": 188.72, "allTimeLow": 4.11, "priceToSalesTrailing12Months": 2.1921859, "fiftyDayAverage": 6.9368, "twoHundredDayAverage": 12.56755, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 59573404, "profitMargins": -0.68349, "floatShares": 26273357, "sharesOutstanding": 28414279, "sharesShort": 7159495, "sharesShortPriorMonth": 7810428, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.252, "heldPercentInsiders": 0.0754, "heldPercentInstitutions": 0.86691004, "shortRatio": 10.11, "shortPercentOfFloat": 0.3803, "impliedSharesOutstanding": 28414279, "bookValue": 8.245, "priceToBook": 0.9132808, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -66709000, "trailingEps": -2.46, "forwardEps": -2.65956, "lastSplitFactor": "1:7", "lastSplitDate": 1510790400, "enterpriseToRevenue": 0.61, "enterpriseToEbitda": -0.792, "52WeekChange": -0.539721, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 7.53, "targetHighPrice": 72.0, "targetLowPrice": 7.0, "targetMeanPrice": 33.55556, "targetMedianPrice": 20.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 180360000, "totalCashPerShare": 6.348, "ebitda": -75185000, "totalDebt": 25987000, "quickRatio": 5.941, "currentRatio": 7.861, "totalRevenue": 97601000, "debtToEquity": 11.572, "revenuePerShare": 3.598, "returnOnAssets": -0.14998001, "returnOnEquity": -0.27427998, "grossProfits": -94394000, "freeCashflow": -32196876, "operatingCashflow": -58328000, "revenueGrowth": -0.588, "grossMargins": -0.96713996, "ebitdaMargins": -0.77032995, "operatingMargins": -0.96274, "financialCurrency": "USD", "symbol": "ARCT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 7.54, "postMarketChange": 0.009999752, "regularMarketChange": -0.0599999, "regularMarketDayRange": "7.41 - 7.76", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 837955, "fiftyTwoWeekLowChange": 1.6800003, "fiftyTwoWeekLowChangePercent": 0.28717953, "fiftyTwoWeekRange": "5.85 - 24.17", "fiftyTwoWeekHighChange": -16.64, "fiftyTwoWeekHighChangePercent": -0.6884567, "fiftyTwoWeekChangePercent": -53.9721, "dividendDate": 1510790400, "earningsTimestamp": 1762808400, "earningsTimestampStart": 1762808400, "earningsTimestampEnd": 1762808400, "shortName": "Arcturus Therapeutics Holdings ", "longName": "Arcturus Therapeutics Holdings Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1369229400000, "corporateActions": [], "postMarketTime": 1769215245, "regularMarketTime": 1769202002, "exchange": "NGM", "messageBoardId": "finmb_235062181", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.790513, "regularMarketPrice": 7.53, "marketState": "CLOSED", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "postMarketChangePercent": 0.13279884, "earningsCallTimestampStart": 1762810200, "earningsCallTimestampEnd": 1762810200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.46, "epsForward": -2.65956, "epsCurrentYear": -2.11754, "priceEpsCurrentYear": -3.5560133, "fiftyDayAverageChange": 0.5932002, "fiftyDayAverageChangePercent": 0.08551496, "twoHundredDayAverageChange": -5.0375495, "twoHundredDayAverageChangePercent": -0.40083784, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "Arcturus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]